Adverse reactions and safety of newer disease-modifying antirheumatic drugs (DMARDs) for rheumatoid arthritis

Novel immunomodulating treatments for rheumatoid arthritis, including abatacept and rituximab, have powerful effects. Adverse reactions include severe infection, anaphylaxis and possible increases in rare neurological disorders.